[go: up one dir, main page]

DK1446119T3 - Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse - Google Patents

Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse

Info

Publication number
DK1446119T3
DK1446119T3 DK02765268T DK02765268T DK1446119T3 DK 1446119 T3 DK1446119 T3 DK 1446119T3 DK 02765268 T DK02765268 T DK 02765268T DK 02765268 T DK02765268 T DK 02765268T DK 1446119 T3 DK1446119 T3 DK 1446119T3
Authority
DK
Denmark
Prior art keywords
compositions
common cold
ipratropium
xylometazoline
treatment
Prior art date
Application number
DK02765268T
Other languages
Danish (da)
English (en)
Inventor
Hanne Anette Moesgaard
Karin Lowenstein Christensen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Application granted granted Critical
Publication of DK1446119T3 publication Critical patent/DK1446119T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK02765268T 2001-09-18 2002-09-18 Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse DK1446119T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (fr) 2001-09-18 2002-09-18 Compositions pour traiter le rhume

Publications (1)

Publication Number Publication Date
DK1446119T3 true DK1446119T3 (da) 2006-07-10

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02765268T DK1446119T3 (da) 2001-09-18 2002-09-18 Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse

Country Status (20)

Country Link
US (2) US7652030B2 (fr)
EP (2) EP1661570A3 (fr)
JP (1) JP4500045B2 (fr)
KR (1) KR100810872B1 (fr)
CN (1) CN1290502C (fr)
AT (1) ATE318601T1 (fr)
BR (1) BRPI0212586B8 (fr)
CA (1) CA2460140C (fr)
DE (1) DE60209511T2 (fr)
DK (1) DK1446119T3 (fr)
EA (1) EA008165B1 (fr)
ES (1) ES2259098T3 (fr)
HU (1) HU226527B1 (fr)
MX (1) MXPA04002500A (fr)
NO (1) NO334441B1 (fr)
NZ (1) NZ531792A (fr)
PL (1) PL208686B1 (fr)
PT (1) PT1446119E (fr)
SI (1) SI1446119T1 (fr)
WO (1) WO2003024433A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1713472A2 (fr) * 2004-02-06 2006-10-25 MEDA Pharma GmbH & Co. KG Traitement de la rhinite avec des anticholinergiques seuls ou combines a des antihistaminiques, des inhibiteurs de phosphodiesterase 4, ou des corticosteroides
WO2005084330A2 (fr) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions et methodes de traitement de la congestion nasale
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
KR100866720B1 (ko) * 2004-12-27 2008-11-05 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매 약물의 안정화 방법
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
AP3141A (en) 2009-11-25 2015-02-28 Boehringer Ingelheim Int Nebulizer
WO2011064163A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
EP2978407B1 (fr) * 2013-03-29 2020-05-06 Santa Farma Ilaç Sanayi A.S. Composition de solution aqueuse contenant de l'ipratropium et de l'oxymétazoline
WO2014158118A1 (fr) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Composition de suspension contenant de ipratropium et de oxymétazoline
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (fr) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Atomiseur
WO2015054359A1 (fr) * 2013-10-08 2015-04-16 Ebadi Mark A Procédés et compositions pour le traitement symptomatique du rhume
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
EP3139984B1 (fr) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nébuliseur
CN106456913B (zh) 2014-05-07 2019-08-30 勃林格殷格翰国际有限公司 喷雾器和容器
EA032719B1 (ru) * 2014-12-24 2019-07-31 Ярдан-Галенски Лабораторий Д.Д. Назальная лекарственная форма против заложенности носа
MX383771B (es) * 2015-12-02 2025-03-14 Pablo Cortes Borrego Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08508007A (ja) 1991-11-19 1996-08-27 センター フォー イノベイティブ テクノロジー ウィルス抑止性抗両受体によるかぜの複合治療法
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
WO1994013263A1 (fr) 1992-12-09 1994-06-23 Jager Paul D Formulations en aerosol de solutions medicinales stabilisees
EP0780127A1 (fr) 1995-12-19 1997-06-25 The Procter & Gamble Company Pulvérisateur nasale contenant un stéréoide et un antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
IL131492A0 (en) * 1997-04-30 2001-01-28 Warner Lambert Co Topical nasal antiinflammatory compositions
PT1051155E (pt) * 1998-01-30 2002-10-31 Novartis Consumer Health Sa Solucoes nasais
EP1087750B1 (fr) 1998-06-18 2003-11-12 Boehringer Ingelheim Pharmaceuticals Inc. Preparations pharmaceutiques pour aerosols a deux principes actifs ou plus
PT1194145E (pt) 1999-06-22 2003-06-30 Boehringer Ingelheim Int Solucao estavel de xilometazolina e de oximetazolina
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli

Also Published As

Publication number Publication date
EP1661570A2 (fr) 2006-05-31
JP4500045B2 (ja) 2010-07-14
CA2460140A1 (fr) 2003-03-27
CN1290502C (zh) 2006-12-20
DE60209511D1 (de) 2006-04-27
JP2005505569A (ja) 2005-02-24
PT1446119E (pt) 2006-07-31
PL370536A1 (en) 2005-05-30
HUP0402075A2 (hu) 2005-02-28
EP1661570A3 (fr) 2012-10-24
PL208686B1 (pl) 2011-05-31
SI1446119T1 (sl) 2006-08-31
CA2460140C (fr) 2009-09-01
NO334441B1 (no) 2014-03-03
US20100093783A1 (en) 2010-04-15
BR0212586A (pt) 2004-10-13
HU226527B1 (hu) 2009-03-30
CN1555263A (zh) 2004-12-15
EA008165B1 (ru) 2007-04-27
NZ531792A (en) 2006-02-24
KR100810872B1 (ko) 2008-03-06
ES2259098T3 (es) 2006-09-16
EP1446119A2 (fr) 2004-08-18
ATE318601T1 (de) 2006-03-15
BR0212586B1 (pt) 2013-11-19
MXPA04002500A (es) 2004-11-22
DE60209511T2 (de) 2006-10-05
WO2003024433A2 (fr) 2003-03-27
EP1446119B1 (fr) 2006-03-01
HK1067984A1 (en) 2005-04-22
US7652030B2 (en) 2010-01-26
EA200400444A1 (ru) 2005-02-24
US8450339B2 (en) 2013-05-28
KR20040049849A (ko) 2004-06-12
NO20041070L (no) 2004-05-18
BRPI0212586B8 (pt) 2021-05-25
HUP0402075A3 (en) 2008-04-28
WO2003024433A3 (fr) 2004-06-10
US20040248924A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
DK1446119T3 (da) Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
BR0313176A (pt) Composições de pirazol úteis como inibidores de gsk-3
BR9812361A (pt) Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
SE0101932D0 (sv) Pharmaceutical combinations
NO2007010I2 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
DK1307189T3 (da) Anvendelse af hydroxyethylrutosider til behandling af forkölelsessymptomer, allergiske rhinitis og infektioner relateret til luftvejene
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
GB0222514D0 (en) Organic compounds
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
WO2003087049A3 (fr) Combinaisons de produits pharmaceutiques contenant des composes heterocycliques et un nouvel anticholinergique
SG152257A1 (en) Topical preparation containing ambroxol
BR0212329A (pt) Métodos para tratar doença pulmonar
ECSP055844A (es) Nuevos compuestos triciclicos
WO2005039483A3 (fr) Compositions pharmaceutiques anti-inflammatoires permettant de reduire une inflammation et traitement ou prevention de la toxicite gastrique
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
SE0002353D0 (sv) New use
NO20030021D0 (no) Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV
WO2003043614A3 (fr) Agents utiles pour le traitement des troubles des voies aeriennes
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы